Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor CellsJacob George, Arie Roth, Haim Shmilovich et al.|Tissue Engineering|2006Cited by 137
The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosisYoav Michowitz, Jacob George, Emil Goldstein et al.|Journal of the American College of Cardiology|2005Cited by 130
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failureJacob George, Gad Keren, Shuki Patal et al.|American Heart Journal|2005Cited by 129
Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarctionGabriel I. Barbash, Elieser Kaplinsky, Arie Roth et al.|The American Journal of Cardiology|1990Cited by 101
Shoulo thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot studyArie Roth, Shlomo Laniado, Gabriel I. Barbash et al.|Journal of the American College of Cardiology|1990Cited by 98